APA   Click to copy
Roviello, G., Corona, S. P., Bozza, G., Aieta, M., Generali, D., Rodriquenz, M. G., … Sobhani, N. (2018). Lenvatinib for the treatment of renal cell carcinoma. Expert Opinion Investigational Drugs, 27(5), 507–512. https://doi.org/10.1080/13543784.2018.1472235

Chicago/Turabian   Click to copy
Roviello, Giandomenico, Silvia Paola Corona, Giovanni Bozza, Michele Aieta, Daniele Generali, Maria Grazia Rodriquenz, Anna Maria Mileo, et al. “Lenvatinib for the Treatment of Renal Cell Carcinoma.” Expert Opinion Investigational Drugs 27, no. 5 (2018): 507–512.

MLA   Click to copy
Roviello, Giandomenico, et al. “Lenvatinib for the Treatment of Renal Cell Carcinoma.” Expert Opinion Investigational Drugs, vol. 27, no. 5, 2018, pp. 507–12, doi:10.1080/13543784.2018.1472235.

@article{giandomenico2018a,
  title = {Lenvatinib for the treatment of renal cell carcinoma},
  year = {2018},
  issue = {5},
  journal = {Expert Opinion Investigational Drugs},
  pages = {507-512},
  volume = {27},
  doi = {10.1080/13543784.2018.1472235},
  author = {Roviello, Giandomenico and Corona, Silvia Paola and Bozza, Giovanni and Aieta, Michele and Generali, Daniele and Rodriquenz, Maria Grazia and Mileo, Anna Maria and Imperatori, Marco and Ianza, Anna and Conca, Raffaele and Sobhani, Navid}
}